Pegaspargase News
Pegaspargase currently has 0 news articles, with 10 predicted indications.
This page combines the AI-predicted indications for Pegaspargase with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Predicted indications (10):
- precursor lymphoblastic lymphoma/leukemia (100.0%)
- pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma (100.0%)
- chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation (100.0%)
- follicular lymphoma (99.9%)
- acute lymphoblastic leukemia (99.9%)
- methylcobalamin deficiency type cblE (99.7%)
- lymphoid neoplasm (99.7%)
- Hodgkins lymphoma (99.7%)
- chronic lymphocytic leukemia/small lymphocytic lymphoma (99.7%)
- blast phase chronic myelogenous leukemia, BCR-ABL1 positive (99.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.